Mark Senak is a new contributor to Seeking Alpha who will soon submit a bio.
Note: Seeking Alpha editors have contact information for all contributors, to enable ongoing communication regarding articles published.
Mark Senak's Latest Articles
-
Bayer's Deadly Drug Poses Challenge to FDA Safety Policies
on Feb 20, 2008
about
BAY
-
Merck Makes Another OTC Attempt for Mevacor
on Oct 30, 2007
about
MRK
-
J&J Sues The American Red Cross: The Beauty Of Corporate Blogging
on Aug 17, 2007
about
JNJ
-
IBS Drugs By Novartis And GlaxoSmithKline Returned To Market Despite Safety Issues
on Jul 31, 2007
about
NVS,
GSK
-
Bad News For Neurochem: FDA Issues Another Approvable Letter
on Jul 19, 2007
about
BLUS
-
Foreign Pharma Suppliers Need To Be Communicative About Safety
on Jun 19, 2007
-
Congress To Examine FDA's Handling of GlaxoSmithKline's Diabetes Drug
on May 23, 2007
about
GSK
-
On FDA Response Letters and Dendreon's Provenge
on May 10, 2007
about
DNDN
-
Pharmacogenomics: Genentech, OSI and Other Pharmas Personalize Medicine
-
HPV Vaccine Mandates - State Update
on Feb 27, 2007
about
MRK
-
FDA Limits Use of Sanofi-Aventis's Drug
on Feb 14, 2007
about
SNY
-
Mandatory Vaccination with Merck's Gardasil Raises Eyebrows
on Feb 07, 2007
about
MRK
-
Democrats Push for Medicare Part D Reform
on Jan 10, 2007
-
FDA Approvable Letters for New River Pharmaceuticals, Shire, Allergan and Perrigo
-
FDA Updates Reporting of Adverse Events
on Dec 21, 2006
Latest Commentson Mark Senak's Articles